Clinical Trials Browser

Completed × HBI-8000 × Other hematologic neoplasm × Clear all

NCT02955589 2024-09-19

Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)

Phase 2 Completed

23 enrolled 15 charts

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma